DAVENPORT FRED B JR 4

What Happened

• Fred B. Davenport Jr., a director of Medpace Holdings, Inc. (MEDP), was granted 1,110 derivative shares (an equity award/option-type grant) on May 15, 2026. The reported acquisition price is $0.00 (typical for a grant); no cash was paid by the insider at grant.

Key Details

• Transaction date: 2026-05-15; filing date: 2026-05-18 (filed within the SEC’s required period).
• Award: 1,110 derivative shares; reported price $0.00 (grant).
• Shares owned after transaction: not specified in the reported Form 4.
• Footnotes: F1 — award is held in a trust for the reporting person’s benefit. F2 — the option vests on the earlier of (i) the day before the issuer’s first annual meeting after grant or (ii) the first anniversary of grant, subject to continued board service.
• Transaction code: A (award/grant).

Context

• This is a director compensation award, not an open‑market purchase or sale. Such grants are commonly used to compensate directors and typically vest over time; they do not necessarily indicate immediate buying or selling of stock.